Overview of mainstream Perp DEXs: trading volumes on all platforms have slightly declined, and overall open interest has experienced minimal fluctuations.

GateUser-6433627c · 2026-02-11T10:24:01+00:00

Data from February 11th shows that trading volumes on major platforms have slightly declined, with Hyperliquid continuing to lead. The trading volumes and open interest are approximately: Hyperliquid at $6.06 billion, EdgeX at $3.02 billion, and Aster at $3.01 billion. Overall, the situation remains stable.

GateUser-6433627c

2026-02-11 10:24:01

Abstract generation in progress

On February 11, according to DefiLlama data, trading volumes across major platforms slightly declined, and the overall open interest remained relatively stable. Among them, Hyperliquid maintained its lead in trading volume, as Aster’s trading volume experienced a significant drop, with EdgeX now ranking second. The current trading volume for major Perp DEXs is as follows: Hyperliquid’s 24-hour trading volume is approximately $6.06 billion, TVL is about $4.22 billion, and open interest is around $4.97 billion; EdgeX’s 24-hour trading volume is approximately $3.02 billion, TVL is about $1.81 billion, and open interest is roughly $1.05 billion; Aster’s 24-hour trading volume is approximately $3.01 billion, TVL is about $1.09 billion, and open interest is around $1.84 billion; Lighter’s 24-hour trading volume is approximately $1.84 billion, TVL is about $915 million, and open interest is roughly $707 million; Grvt’s 24-hour trading volume is approximately $1.63 billion, TVL is about $89.94 million, and open interest is around $396 million; Pacifica’s 24-hour trading volume is approximately $936 million, TVL is about $39.03 million, and open interest is roughly $4.768 million.

HYPE3,49%

ASTER7,32%

LIT-0,62%

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.